Ficha del valor · trimestre archivado
PCRX
Pacira BioSciences, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
15Tenedores rastreados
0Δ titulares
22.66MAcciones mantenidas
$541.65MValor declarado
+1Nuevas posiciones
−1Cierres
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -3.9% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 89 | +2 | 30.85M | $781.81M | +7 | −4 |
| Q1 2026 | 89 | -5 | 30.76M | $694.94M | +2 | −7 |
| Q4 2025 | 94 | -1 | 36.25M | $938.05M | — | −1 |
| Q3 2025 | 19 | +1 | 24.74M | $637.46M | +2 | −1 |
| Q2 2025 | 15 | 0 | 22.66M | $541.65M | +1 | −1 |
| Q1 2025 | 12 | -3 | 10.29M | $255.59M | — | −3 |
| Q4 2024 | 15 | +1 | 11.71M | $220.69M | +1 | — |
| Q3 2024 | 13 | 0 | 9.23M | $138.98M | +1 | −1 |
| Q2 2024 | 13 | — | 6.89M | $197.00M | — | — |
Quién lo tiene en cartera · Q2 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (pasivo) | 7.80M | — | $186.33M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | The Vanguard Group ✦ (pasivo) | 5.41M | — | $129.20M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | The Vanguard Group ✦ (pasivo) | 5.41M | — | $129.20M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | The Vanguard Group ✦ (pasivo) | 5.41M | — | $129.20M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | The Vanguard Group ✦ (pasivo) | 5.41M | — | $129.20M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | The Vanguard Group ✦ (pasivo) | 5.41M | — | $129.20M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Renaissance Technologies ✦ | 2.40M | +6.9% | $57.25M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 24 | D. E. Shaw & Co. ✦ | 2.25M | -0.5% | $53.86M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 2.25M | -0.5% | $53.86M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 2.25M | -0.5% | $53.86M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 27 | D. E. Shaw & Co. ✦ | 2.25M | -0.5% | $53.86M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 28 | State Street Global Advisors ✦ (pasivo) | 1.95M | -1.4% | $46.62M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 29 | Geode Capital Management ✦ (pasivo) | 1.14M | +0.5% | $27.33M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Geode Capital Management ✦ (pasivo) | 1.14M | +0.5% | $27.33M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Wellington Management ✦ | 545.60K | +1.6% | $13.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Wellington Management ✦ | 545.60K | +1.6% | $13.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | Wellington Management ✦ | 545.60K | +1.6% | $13.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | Wellington Management ✦ | 545.60K | +1.6% | $13.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 545.60K | +1.6% | $13.04M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Millennium Management ✦ | 515.02K | +49.0% | $12.31M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 37 | Marshall Wace ✦ | 190.37K | Nuevo | $4.55M | 0.0% | New | 1 | SEC ↗ |
| 38 | Marshall Wace ✦ | 190.37K | Nuevo | $4.55M | 0.0% | New | 1 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 142.16K | -19.6% | $3.40M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 142.16K | -19.6% | $3.40M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 142.16K | -19.6% | $3.40M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 42 | AQR Capital Management ✦ | 142.16K | -19.6% | $3.40M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 43 | Two Sigma Investments ✦ | 106.84K | -9.7% | $2.55M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 44 | Fidelity (FMR) ✦ | 92.68K | — | $2.22M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | Fidelity (FMR) ✦ | 92.68K | — | $2.22M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | Fidelity (FMR) ✦ | 92.68K | — | $2.22M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | Fidelity (FMR) ✦ | 92.68K | — | $2.22M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | T. Rowe Price ✦ | 47.91K | +6.5% | $1.15M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 49 | Gotham Asset Management ✦ | 42.16K | -2.3% | $1.01M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 50 | Arrowstreet Capital ✦ | 35.61K | -47.3% | $850,983 | 0.0% | ▼ Trim | 5 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Marshall Wace | $4.55M | 0.0% |
| Marshall Wace | $4.55M | 0.0% |
Posición cerrada
| Citadel Advisors | $33.05M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 3 tenedores, 13.02M acciones, $12.57M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q2 2025 ·
Metodología ·
Obtener esto a través de la API